A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro, PF Conte… - Cancer chemotherapy …, 2014 - Springer
Background Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …
被引用次数：6 相关文章

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro, PF Conte… - Cancer Chemotherapy …, 2014 - infona.pl
Background Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …

[引用][C] A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro, C PF… - CANCER …, 2014 - iris.hunimed.eu
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with
epirubicin as first-line treatment in metastatic breast cancer IRIS IRIS Home Sfoglia …

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro… - Cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.

S Chan, M Campone, A Santoro, PF Conte… - Cancer …, 2014 - europepmc.org
Background Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro… - Cancer …, 2014 - search.proquest.com
Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids class active in
advanced stage breast cancer. We conducted a phase I study combining VFL with epirubicin …

[引用][C] A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S CHAN, M CAMPONE, A SANTORO… - Cancer …, 2014 - pascal-francis.inist.fr
A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as
first-line treatment in metastatic breast cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.

S Chan, M Campone, A Santoro… - Cancer …, 2014 - search.ebscohost.com
Background: Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S Chan, M Campone, A Santoro, P Conte… - CANCER …, 2014 - research.unipd.it
BACKGROUND: Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca
alkaloids class active in advanced stage breast cancer. We conducted a phase I study …

[引用][C] A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

S CHAN, M CAMPONE, A SANTORO… - Cancer chemotherapy …, 2014 - Springer